Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pr...
Leadership
Sanjeev Luther
CEO, President & Director
Sandra M. Gurrola
Senior VP of Finance
Robert Hamilton Pierce M.D.
Chief Scientific Officer
Dorothy J. Clarke
General Counsel
Kanika Chawla Ph.D.
Senior Vice President of Technical Operations (Consultant)
